Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Magneto-Optic Device Rapidly Detects Malaria

By Labmedica staff writers
Posted on 05 May 2008
A device uses magneto-optic technology (MOT) to detect hemozoin, a waste product of the malarial parasite, in blood in less than a minute.

Hemozoin crystals are weakly magnetic and have a distinct rectangular form. More...
They also exhibit optical dichroism, which means that they absorb light more strongly along their length than across their width. When aligned by a magnetic field they behave like a weak Polaroid sheet such as used in sunglasses.

Engineers from the Universities of Exeter (Devon, UK) and Coventry (Coventry, UK) created the new device, which could be as effective as the rapid diagnostic tests (RDTs) currently used in the field, but much cheaper and faster. The team is now working on a non-invasive version of the device, and with a team from the department of biomedical research, Royal Tropical Institute (KIT; Amsterdam, The Netherlands), is planning to trial in Kenya later in 2008.

RDTs use a chemical agent to detect antigens associated with the malarial parasite. One of the problems with RDTs is that they need to be kept within a given temperature range, which is difficult in hot climates. The disposable kits cost between US$1.50 and $4.50 each and take around 15 minutes to deliver a reading.

High-power microscopy is still the best method available for malaria diagnosis and has been used for more than a century. Unfortunately, it is time-consuming and requires expensive equipment and specialist medical skills, which are rarely available in villages in rural areas in malaria endemic countries. Over the last decade RDTs have been developed, which allow for faster diagnosis in the field, but these are too costly to be viable for developing countries.

In many communities where malaria is having a severe impact on health, there is no testing for malaria and young children who have a fever are given anti-malaria drugs as a matter of course. This has contributed to the malarial parasite becoming increasingly resistant to the common antimalaria drugs. Malaria is a disease for which there is still no vaccine.

Prof. Dave Newman of the University of Exeter's School of Engineering, Computing, and Mathematics, said, "There is an urgent need for a new diagnostic technique for malaria, particularly in the light of global warming, which threatens to spread the disease into new parts of the world, including southern Europe. The early results from our device are very promising and hugely exciting. We expect to ultimately produce a sensitive, noninvasive device that will be cost effective and easy to use, making it suitable for developing countries, where the need is greatest.”

The preliminary results appeared online in the Biophysical Journal in April 2008.


Related Links:
University of Exeter
University of Coventry
Royal Tropical Institute

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.